Targeting antihormone resistance in breast cancer: A simple solution

Annals of Oncology

Volumn 14, Issue 7, 2003, Pages 969-970

  Jordan, V C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIESTROGEN; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DEGUELIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ESTROGEN RECEPTOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAMOXIFEN; TRASTUZUMAB;

ADVANCED CANCER; APOPTOSIS; BREAST CANCER; CANCER SURVIVAL; DIETARY INTAKE; DRUG ACTIVITY; DRUG POTENTIATION; DRUG RESEARCH; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; EDITORIAL; HUMAN; LABORATORY TEST; LUNG CANCER; ONCOGENE NEU; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0042201875     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg306     Document Type: Editorial

References (11)

1. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. The Dorothy P. Landon AACR Prize for Translational Research. Clin Cancer Res 2003; 9: 1980-1989.
2. Harper MJ, Walpole AL. A new derivative of triphenylethylene: effect on implantation and mode of action in rats. J Reprod Fertil 1967; 13: 101-119.
3. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003; 2: 205-213.
4. deGraffenried LA, Friedrichs WE, Fulcher L et al. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol 2003; 14: 1051-1056.
5. Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001; 19: 32S-40S.
6. Campbell RA, Bhat-Nakshatri P, Patel NM et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 2001; 276: 9817-9824.
7. Clark AS, West K, Steicher S et al. Constitutive and inducible akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 2002; 1: 707-717.
8. Mirnikjoo B, Brown SE, Kim HFS et al. Protein kinase inhibition by ω-3 fatty acids. J Biol Chem 2000; 276: 10888-10896.
9. Hardman WE, Reddy Avula CP, Fernandes G et al. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 2001; 7: 2041-2049.
10. Calviello G, Palozza P, Piccioni E et al. Dietary supplementation with eicosapentaenoic and cocosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 1998; 75: 699-705.
11. Chun KH, Kosmeder JW 2nd, Sun S et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 2003; 95: 291-302.